SPCs: Paris court confirms its interpretation of CJEU ‘Royalty Pharma’ test

The Paris Court of Appeal has rejected a patent holder’s interpretation of EU case law that concerns criteria for obtaining supplementary protection certificates (SPCs) for innovations in medicine.

Read Complete Article

MITLA is a member of the INPLP

    Subscribe for the latest
    IT Law updates

    Receive the latest IT Law updates straight to your inbox, gain access to our exclusive industry events, keep up to date with MITLA.